Skip to main content

Advertisement

Open Peer Review Reports for: Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Dec 2006 Submitted Original manuscript
25 Jan 2007 Reviewed Reviewer Report - Anke van den Berg
7 Feb 2007 Reviewed Reviewer Report - Austen Worth
9 Apr 2007 Author responded Author comments - Lixin Zheng
Resubmission - Version 2
9 Apr 2007 Submitted Manuscript version 2
3 May 2007 Reviewed Reviewer Report - Anke van den Berg
5 May 2007 Reviewed Reviewer Report - Austen Worth
1 Jun 2007 Author responded Author comments - Lixin Zheng
Resubmission - Version 3
1 Jun 2007 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
20 Jun 2007 Author responded Author comments - Lixin Zheng
Resubmission - Version 5
20 Jun 2007 Submitted Manuscript version 5
Publishing
2 Jul 2007 Editorially accepted
2 Jul 2007 Article published 10.1186/1471-2350-8-41

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement